Please login to the form below

Not currently logged in
Email:
Password:

ALL

This page shows the latest ALL news and features for those working in and with pharma, biotech and healthcare.

Shire says all its studies will publish in open access journals

Shire says all its studies will publish in open access journals

It believes it is the first biopharma company to implement this open access policy, and also reckons it is the “only company to report the results from all of its clinical ... 60% of all medical research, the industry as a whole has been slow to adopt

Latest news

More from news
Approximately 7 fully matching, plus 1,044 partially matching documents found.

Latest Intelligence

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    After all, so many of today’s life-saving healthcare advances, from cancer chemotherapy to heart surgery, rely on effective antibiotics being available to prevent infections in patients.

  • Brexit Means Brexit Brexit Means Brexit

    The working assumptions are that people on all sides of the negotiation want a positive win/win outcome. ... In an uncertain and ever-evolving environment, the challenge is to prepare for all eventualities.

  • What makes a meaningful brand? What makes a meaningful brand?

    sense of direction by facilitating. decision-making on all. brand-building activities. This foundation should highlight the key features and characteristics that are compelling to audience members and unique within the ... After all,. a brand is a vessel

  • Beyond caring: learning from the unsung advocates in cancer care

    Tragically however, not all patients have an advocate of their own. ... Advocates are faced with all these challenges while also carrying out caring duties day and night as they dedicate themselves to looking after their loved ones.

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    By utilising the initiatives above, biopharmaceutical companies can drive effective partnerships and improve outcomes for all stakeholders and patients in the area of rare disease.

More from intelligence
Approximately 0 fully matching, plus 670 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 271 partially matching documents found.

Latest from PMHub

  • The Lucid Festival of Magic - A Spellbinding Event for All

    The Lucid Festival of Magic - A Spellbinding Event for All. ... Jan Steele Lucid COO and Co-Founder commented, “ The success of Lucid over the last eleven years has surpassed all my expectations.

  • Engaging content is all about emotion

    Engaging content is all about emotion. Instil your healthcare content marketing with enough emotion to move your prospects to take action. ... someone with a terminal illness.In all cases, your readers begin with a problem of some kind.

  • Strategy - It's All About Choices

    Unfortunately there is a trend in practice towards over-complicating what strategy is all about, when it should be kept simple. ... If these critical business challenges are at the heart of your plan then your strategy is all the more likely to be simple

  • Doctor doctor, where are all the men?

    Doctor doctor, where are all the men? New data show that half of men put off visiting the doctor. ... And if it’ s not one of these examples then it’ s something else, we all do it.

  • Virgo Health

    Our approach means we can give our clients the best of all worlds, all over the world. ... Since that day Golin’ s reputation has been one of an innovator and leader in progressive corporate and consumer communications that ‘ Go All In!’.

More from PMHub
Approximately 0 fully matching, plus 1,003 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics